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C H A P T E R 21 
General and exceptional pathways of protein 
import into sub-mitochondrial compartments 
ROLAND LILL, CHRISTOPH HERGERSBERG, HELMUT 
SCHNEIDER, THOMAS SÖLLNER, ROSEMARY STUART 
and WALTER NEUPERT 
Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie der Universität 
München, Goethestraße 33, 8000 München 2, Germany 
1. The general pathways for protein import into sub-mitochondrial 
compartments 
In the past few years, considerable progress has been made to elucidate the mechan-
isms of how nuclear-encoded proteins are imported into and sorted within mito-
chondria (for detailed reviews, see [1-5]). The consensus pathways for protein 
sorting into the different mitochondrial compartments are depicted in Fig. 1. Nucle-
ar encoded mitochondrial proteins are synthesized on cytoplasmic ribosomes as 
precursors which usually contain N-terminal targeting (signal) sequences. These 
signal peptides are positively charged and have the potential to form amphipathic 
a-helices [6]. Some precursor proteins, however, lack such cleavable pre-sequences, 
such as those destined for the mitochondrial outer membrane (OM). To avoid pre-
mature folding or aggregation in the cytosol, the precursors are transiently bound to 
cytosolic chaperone proteins which have been shown to belong to the heat shock 
protein 70 (hsp70) class [7]. Dissociation from hsp70 requires the hydrolysis of ATP 
which, in many cases, is considered to be a rate-limiting step for translocation. 
Specific interaction of most precursor proteins with the O M is mediated by 
protease-sensitive surface receptors. Neurospora crassa M O M 19 acts as the receptor 
for the majority of proteins analyzed so far [8], whereas the participation of N. crassa 
M O M 72 has been demonstrated only in connection with the import of the ADP/ATP 
carrier [9]. Its yeast counterpart, MAS70, appears to have a broader substrate 
specificity [10,11]. Translocation through or insertion into the O M is catalyzed by 
a number of proteins which are associated in a complex in the O M (Fig. 1). This 
complex (termed the receptor/GIP complex) has been identified by co-immunopre-
cipitation with the surface receptors M O M 19 or MOM72 which are part of the 
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Fig. 1. The general pathways of protein import into sub-mitochondrial compartments. See text for a 
detailed explanation. It should be noted here that we do not know the specific interactions between the 
individual components of the receptor/GIP complex in the OM. However, according to their protease-
resistance, MOM38, MOM30, MOM8, and MOM7 are deeply inserted into the OM or are even exposed 
to the IMS, while MOM 19 and MOM72, as surface receptors, and MOM22 face the cytosol. Consistent 
with this observation it has been demonstrated that the former set of proteins forms (at least part of) GIP, 
a site where precursor proteins like A A C are already deeply inserted into the OM and are protected from 
externally added protease. Aside from its co-immunoprecipitation with MOM 19, the role of MOM22 is 
unknown at present. For the sake of clarity, the second proteolytic step occurring in the IMS after export 
of proteins from the matrix has been omitted. Proteins inserted into the OM normally do not contain 
cleavable signal sequences (see text). I B M , inner boundary membrane; MOMx, mitochondrial outer 
membrane protein with a molecular mass of x kDa. MPP, matrix processing peptidase; PEP, processing 
enhancing protein; Cyt and mt hsp70, cytosolic and mitochondrial isoforms of heat shock protein of 70 
kDa; Hsp60, heat shock protein of 60 kDa; ?, unknown components of the protein import and export 
apparatus of the I M . 
complex [12]. One of its components, N. crassa MOM38, is part of a translocation site 
in which the precursor proteins are already deeply inserted in the O M and thus are 
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resistant to externally added protease. Since this site is used by most precursor 
proteins, it has been termed general insertion pore (GIP) [13]. The yeast counterpart 
of MOM38, ISP42, is essential for cell growth [14]. Both functional and structural 
analysis of the receptor/GIP complex has been achieved by crosslinking the precursor 
of the ADP/ATP carrier (AAC) to various components of the complex [15]. Cross-
linking of A A C arrested at different stages of its passage through the O M [16] allowed 
the components acting early and late in the O M translocation reaction to be defined. 
Receptor-bound A A C could be crosslinked to M O M 19 and MOM72, whereas A A C 
arrested at the level of GIP could be shown to react efficiently with M O M 7 , M O M 8 , 
and with MOM30 proteins thus identifying new members of the complex. 
Proteins destined for the intermembrane space (IMS), the inner membrane ( IM) , 
and the matrix become further translocated through the I M at sites of close contact 
between O M and I M [17]. Under in vivo conditions, more than 90% of the O M 
surface is in close contact with parts of the I M , the inner boundary membrane, which 
is competent for protein import (Fig. 1). Only a fraction of this area (10%) is made up 
of the morphological contact sites which comprise stable attachments of O M and I M 
even after shrinking of the I M . The initial interaction of the precursor proteins with 
the I M is mediated through an N-terminal signal sequence, and translocation is 
dependent on a membrane potential across the I M . Nothing is known so far about 
the nature of the components of the I M import machinery. The action of mitochon-
drial hsp70 (located in the matrix) and ATP hydrolysis are thought to be needed to 
pull the proteins into the matrix and are required for subsequent folding of matrix 
proteins [18]. N-terminal signal sequences are cleaved off by the matrix processing 
peptidase consisting of two components (MPP and PEP in N. crassa, MAS1 and 
MAS2 in yeast). Some of the incoming proteins also interact with hsp60 in the matrix 
which assists in folding and assembly of the incoming proteins [19-21]. 
Proteins of the I M or the IMS are then retargeted into the I M . A second signal 
sequence which shows a close similarity to bacterial export signals mediates this 
interaction. I M proteins become inserted into the I M , while proteins destined for the 
IMS are completely translocated through the I M . Finally, the second signal sequence 
becomes cleaved, e.g., by the inner membrane protease [22], whereafter I M proteins 
are functionally assembled, and IMS proteins are released as soluble proteins into the 
IMS. Since this membrane transit step mechanistically resembles the path taken by 
proteins in the bacterial ancestors of mitochondria, it has been termed the 'con-
servative sorting pathway' [2]. Nothing is known so far about the re-translocation 
(export) apparatus in the I M . One may speculate though that the components of such 
a translocation complex may bear some similarity to the members of the protein 
translocase identified in the plasma membrane of bacteria [23]. 
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2. Exceptional pathways of protein import 
A few exceptions to the general protein import pathways into the sub-mitochondria! 
compartments have been described so far. In these cases, only some steps or compo-
nents of the general pathways are used while others are bypassed or alternative 
routes are taken. For example, import of yeast cytochrome c oxidase subunit Va, a 
protein of the I M (Cox Va) [24], is independent of protease-sensitive surface recep-
tors in the O M . The protein enters the O M obviously at a later stage, most likely at 
the GIP stage, thereby circumventing the participation of surface receptors. The 
import of Cox Va is independent of surface receptors, and is similar to the situation 
found for M O M 19 (see below) and for a low-efficiency bypass import of several 
proteins that was observed even after the surface receptors had been completely 
degraded [25]. For delivery of the Cox Va precursor protein to the O M , hsp70 
seems not to be involved, since comparatively low levels of ATP are needed, and 
import occurs efficiently even at low temperatures. On the other hand, import of 
Cox Va is reported to share the features of the general pathway in that (i) transloca-
tion occurs via translocation contact sites, (ii) it needs a membrane potential for 
translocation, and (iii) its pre-sequence is cleaved after import. 
A non-conservative import pathway into the I M without a transient passage 
through the matrix has been reported for the N. crassa ADP/ATP carrier protein 
(AAC)[26]. As mentioned above, A A C is so far the only known precursor that uses 
MOM72 instead of M O M 19, as an import receptor. From MOM72, A A C is 
transferred into the protease-resistant location of GIP. Dependent on a membrane-
potential across the I M , but independent of ATP and hsp60, as found for proteins of 
the general pathway, A A C is directly inserted into the I M and functionally assembled 
[26]. In vivo experiments with subunit V I of yeast Q H 2 cytochrome c reductase 
(SubVI) suggest a direct transfer of this protein to the outer face of the I M [27]. 
The import into mitochondria is thought to be governed by its unusual N-terminal 
pre-sequence which is 25 amino acids long, but, in contrast to normal signal 
sequences, is highly negatively charged. Fusion proteins of the pre-sequence with 
the mature part of superoxide dismutase (SOD) as a reporter protein (pre-SubVI-
SOD) were transported into the IMS as analyzed by sub-mitochondrial fractionation 
after in vivo import into mitochondria [27]. Furthermore, p re-Sub VI-SOD failed to 
complement a mutant in the matrix-localized SOD also suggesting no transport of the 
fusion protein to the matrix. Thus, a negatively charged pre-sequence is also able to 
direct proteins into mitochondria, and seems to contain the information that pre-
cludes transfer of the attached protein across the I M . 
Import of A A C and a few other mitochondrial proteins is unusual with respect to 
the absence of a cleavable signal sequence at the N-terminus of these proteins. In 
some cases, the sorting signals have been located somewhere in the mature region of 
the proteins, usually close to the N-terminus. Examples with non-cleavable signal 
sequences include the O M proteins MAS70 of yeast, N. crassa MOM72, and porin 
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(see above), as well as AAC, 3-oxoacyl-CoA thiolase (reviewed in [1]), and some 
ribosomal proteins [28]. Many of these ribosomal proteins might lack a separate 
signal, since this class of proteins is usually highly positively charged, and thus 
already contains sequences that are similar to standard signal sequences. 
In contrast to these proteins which use at least parts of the consensus pathway, 
cytochrome c, a soluble protein of the IMS, has developed quite an exceptional 
pathway that has no connection to the general routes. Cytochrome c is imported 
through the O M without the need for protease-sensitive surface receptors or the O M 
import receptor complex described above (for a review see [29]). Rather, cytochrome 
c utilizes a high-affinity interaction with cytochrome c heme lyase (CCHL) for its 
specific import into mitochondria. CCHL covalently attaches the heme group to 
cytochrome c and is located in the IMS at the outer face of the I M . Heme attachment 
may already occur when cytochrome c is still bound to the O M in a trans-membrane 
fashion [30]. Folding of the protein chain around the hydrophobic heme group may 
then lead to the release of functional holocytochrome c into the IMS. Thus, CCHL, 
during the biogenesis of cytochrome c, provides a dual function: (i) as an import 
receptor specific for cytochrome c, and (ii) as an enzyme which covalently adds the 
prosthetic group to the incoming cytochrome c thus rendering the import reaction 
irreversible. 
The study of exceptional import pathways into mitochondria is rewarding in many 
aspects. First, it provides information about new components involved in protein 
transport across membranes. Second, it helps to elucidate the function of certain 
components of the general pathway, e.g., the determinants of recognition by these 
components. Third, it may serve to understand how import into mitochondria is 
regulated in order to achieve a balance between imported material and import 
catalysts. We have studied the import pathways of two proteins, the O M protein 
M O M 19 and CCHL of the IMS, in some detail. Both proteins are imported along 
interesting, novel pathways into mitochondria. 
3. MOM 19 is imported into the OM without the aid of surface receptors 
M O M 19 is the major surface receptor for protein import into N. crassa mitochon-
dria which is used by most precursor proteins analyzed so far [8]. I t was interesting 
to see how M O M 19 itself is delivered to mitochondria. To study its import pathway, 
we first cloned the cDNA and determined the protein sequence [31]. As expected for 
an O M protein, M O M 19 does not contain a cleavable N-terminal signal sequence. 
Residues 42-59 may form a highly positively charged, amphipathic a-helix and may 
serve as an internal, uncleaved import signal. The first 26 amino acids are hydro-
phobic and may represent the membrane anchor for the protein. The rest of the 
protein is hydrophilic and most likely protrudes into the cytosol. 
For the analysis of the in vitro import of M O M 19 into isolated N, crassa 
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mitochondria, we made use of a property of endogenous M O M 19. Treatment of 
mitochondria with elastase produces characteristic fragments of M O M 19. When 
M O M 19 precursor was imported in vitro from reticulocyte lysate, the same proteo-
lytic pattern as that with endogenous M O M 19 was produced after elastase treatment. 
M O M 19 in reticulocyte lysate or M O M 19 bound to the surface of mitochondria did 
not give rise to the specific proteolytic pattern, but was further degraded under the 
conditions used. These results indicate that imported M O M 19 was functionally 
inserted into the O M [31]. 
Which components are involved in the insertion of M O M 19 into the OM? When 
the mitochondria were pre-treated with protease to degrade the endogenous surface 
receptors, namely M O M 19 and MOM72, the import of M O M 19 was unaffected. 
This result shows that M O M 19 does not utilize one of the protease-sensitive surface 
receptors in the O M for its own import. How, then, does M O M 19 become specifically 
imported into mitochondria and does not associate with other cellular membranes 
like microsomes [31]? One possibility is that M O M 19 enters the mitochondria via 
MOM38 with which it forms a tight complex [12]. Since N. crassa MOM38 is 
inaccessible to protease and its function cannot be blocked by antibodies, we made 
use of the yeast homolog of MOM38, namely ISP42, which in contrast is accessible to 
antibodies [32]. N. crassa M O M 19 was imported into yeast mitochondria and 
functionally assembled into the receptor complex as shown by co-immunoprecipita-
tion of M O M 19 with anti-ISP42 antibodies. This heterologous import and assembly 
of M O M 19 also suggests that the receptor complexes of yeast and N. crassa are 
functionally very similar. Mitochondria which were pre-blocked with anti-ISP42 
antibody failed to import MOM19 [31], demonstrating that ISP42 is directly in-
volved in the import of M O M 19. Since the N. crassa homolog of ISP42, MOM38, is a 
component of GIP, these results suggest that M O M 19 enters the mitochondria 
directly at the level of the GIP site thereby bypassing the surface receptors. The 
same conclusion can be drawn from import experiments with yeast mitochondria pre-
treated with protease at concentrations which degraded the receptors but not ISP42. 
Import of M O M 19 into such mitochondria remained unaffected, when import of 
other, receptor-dependent proteins had already vanished. 
For other components of the mitochondrial protein import machinery it has been 
shown that they participate in their own biogenesis. Examples include mitochondrial 
hsp60 [20], hsp70 [33], and the matrix processing peptidase [34]. Why does M O M 19 
circumvent the use of protease-sensitive surface receptors like M O M 19 itself? The 
receptor-independent pathway entering the O M at MOM38/GIP might represent an 
evolutionary remnant form of mitochondrial protein import allowing specific import 
without the need of surface receptors. The invention of surface receptors might then 
serve a dual function: (i) it increases the specificity for import by the introduction of 
another checkpoint in addition to MOM38/GIP; (ii) it increases the efficiency and the 
rate of import considerably. In line with these assumptions, a low efficiency import of 
several proteins into mitochondria was found even after the surface receptors had 
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been removed by protease digestion [25]. Most likely, these proteins enter the 
mitochondria at a later step. 
4. Cytochrome c heme lyase is imported directly through the OM via a 
non-conservative sorting pathway 
N. crassa cytochrome c heme lyase (CCHL) is localized in the IMS, where it is found 
associated with the outer face of the I M [30]. The enzyme catalyzes the covalent 
attachment of a reduced heme group to cytochrome c, and it serves as a high-
affinity receptor for cytochrome c during its import across the O M [29]. N. crassa 
C C H L is about 60% homologous (40% identity on amino acid level) to both yeast 
CCHL and to yeast cytochrome C\ heme lyase ( C Q H L [35,36; A. Haid, pers. com-
mun.]). A l l three heme lyases lack cleavable N-terminal signal sequences. We have 
analyzed the import pathway of N. crassa CCHL in vitro and found an interesting 
import mechanism which, on the one hand, shares characteristics of the general 
pathway (see Fig. 1), and on the other hand, uses novel ways to reach the IMS. 
CCHL synthesized in an in vitro transcription-translation system efficiently and 
rapidly associates with mitochondria [37]. During further incubation, CCHL be-
comes translocated into the organelles, as assayed by protection of imported CCHL 
against digestion by externally added protease. As revealed by digitonin fractionation 
of mitochondria, imported CCHL is correctly localized to the IMS, its functional 
environment. Here, it is bound to membranes, and thus behaves indistinguishably 
from the endogenous protein [30] and its enzyme activity [38]. 
CCHL does not require free ATP for import into mitochondria, an observation 
which is in sharp contrast to what has been reported for other mitochondrial 
precursor proteins. Except for a requirement of ATP in the matrix (see above), 
ATP hydrolysis is needed for the dissociation of the precursor proteins from 
cytosolic hsp70 proteins. Hsp70s bind to precursor proteins in order to keep them 
competent for translocation by stabilizing an unfolded conformation [7]. Dissocia-
tion from hsp70 is assumed to be the rate-limiting step for translocation. For the 
import of CCHL, however, several observations argue against a participation of 
cytosolic hsp70 proteins [37]. (i) CCHL is rapidly imported into the IMS. Even at 0°C 
import occurs with a half-time of 10 min, and thus is much faster than observed for 
other precursors, (ii) The time course and the efficiency of the import are unchanged 
when CCHL is denatured in 8 M urea and imported into mitochondria after rapid 
dilution of the denaturant. Usually, unfolding of the precursor proteins and disrup-
tion of the interaction with hsp70 accelerates the import kinetics markedly, (iii) 
CCHL import occurs independently of the presence of free ATP. When ATP is 
hydrolyzed by apyrase (an ATP- and ADP-hydrolyzing enzyme activity from pota-
to), import of CCHL is unaffected, while the import of control proteins like the ß-
subunit of the F r ATPase is completely inhibited. CCHL imported in the absence of 
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ATP is still correctly localized in the IMS indicating that CCHL is not simply trapped 
in an intermediate stage during import. The observation that CCHL import does not 
involve both hsp70 and the hydrolysis of free ATP may be related to the unusually 
high content of proline residues (11.6%) which might keep the protein in an extended, 
import-competent structure without the aid of chaperone proteins. 
For translocation through the O M , CCHL uses the receptor/GIP complex. Import 
of C C H L was completely abolished when mitochondria were pre-treated with 
protease indicating that protease-sensitive receptors mediate the entry of CCHL 
into the O M [37]. To find out which specific receptor is used, mitochondria were 
pre-incubated with immunoglobulin G (IgG) against M O M 19, MOM72, and as a 
control, porin. Subsequent import of CCHL was specifically reduced by 80% in 
mitochondria that had been blocked with ant i -MOM 19 antibodies as compared to 
unblocked mitochondria, while the other antibodies did not reduce the import 
efficiency. These results demonstrate that CCHL, as most other mitochondrial 
precursor proteins, uses the main receptor of N. crassa mitochondria, M O M 19, for 
initial interaction with mitochondria. Furthermore, competition experiments with 
chemical amounts of import-competent porin demonstrate that CCHL uses the same 
O M import machinery, namely the receptor/GIP complex which is effective for most 
other mitochondrial precursor proteins [37]. 
How does CCHL reach the IMS after transit through the OM? Two possibilities 
can be envisaged. Either, the protein is further translocated via contact sites through 
the I M and the matrix along the conservative sorting pathway (Fig. 1), or it enters the 
IMS directly after its passage through the O M (Fig. 2A). The first possibility seems 
unlikely from the fact that CCHL lacks the usual bipartite, cleavable pre-sequence (as 
found in, e.g., cytochrome c\- and cytochrome ^-precursors). The positively charged 
signal sequence is thought to mediate the interaction with the I M . For insertion and 
translocation through the I M , a membrane potential has been shown to be essential 
[3,39]. Consistent with the view that CCHL translocates directly into the IMS, its 
import into mitochondria occurs independently of the existence of a membrane 
potential [37]. Depletion of the membrane potential by uncouplers like CCCP did 
not influence the import of CCHL into mitochondria. The same result was obtained 
when either ionophores (valinomycin) or inhibitors of the electron transport chain 
and of the FiF 0-ATPase (antimycin A and oligomycin, respectively) were used to 
prevent the formation of a membrane potential. These results strongly suggest that 
CCHL does not pass through the I M during its import into mitochondria. Rather, it 
reaches the IMS directly after translocation through the O M import channel via a 
non-conservative sorting pathway. 
The fact that CCHL requires neither ATP hydrolysis nor a membrane potential as 
energy sources for import, raises the important question of what energetically drives 
the import reaction. Three possibilities may be anticipated, (i) The driving force for 
import may come from folding of CCHL within the IMS. It will be interesting to see 
whether such folding reaction is catalyzed by yet to be discovered factors, (ii) 
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A) C C H L precursor B) pre cyt b 2 - C C H L 
Fig. 2. (A) The non-conservative import pathway of C C H L across the O M and (B) the two-step import 
mechanism of C C H L carrying an N-terminal matrix targeting sequence. See text for a detailed 
explanation. Pre cyt Ö2-CCHL represents C C H L with the positively charged pre-sequence of cytochrome 
b2 (shown by the hatched rectangle) attached to its N-terminus; M1M, mitochondrial inner membrane 
import apparatus; GIP, general insertion pore. All other abbreviations are as in Fig. 1. 
Alternatively, CCHL may be pulled into the IMS by specific interaction with a 
binding partner. Since CCHL avidly binds to liposomes, such an interaction may 
include binding to lipid molecules in the I M and O M . (iii) Finally, it cannot be 
excluded on the basis of the previous experiments (see above) that the hydrolysis of 
miniscule amounts of factor-bound ATP, inaccessible to digestion by apyrase, may 
drive the import. It should be mentioned here that MOM38 contains an ATP binding 
motif [12], and thus may be a candidate for such an ATP binding factor. These 
questions are now open to direct experimental approach. Recently, an in vitro import 
system with purified O M vesicles has been developed. CCHL as well as O M proteins 
are imported into these vesicles in a receptor-dependent fashion (A. Mayer, R. Li l l 
and W. Neupert, unpublished results). The ability of O M vesicles to import CCHL 
nicely confirms the conclusions drawn above that the I M is not involved in the 
passage of CCHL into the IMS. 
Which signals guide CCHL along its path to the IMS and why is further transloca-
tion through the I M precluded? The import signal in CCHL is unknown. Experi-
ments with antibodies raised against the N - and C-terminus of CCHL show that the 
N-terminal half of CCHL inserts into the O M first and thus must contain the 
information for O M interaction (R. Li l l and W. Neupert, unpublished results). Both 
antibodies efficiently block translocation of CCHL. When import is inhibited by the 
C-terminal antibodies, specific N-terminal fragments of CCHL are produced after 
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protease digestion. Occurrence of these fragments is dependent on functional 
M O M 19 protein and is not observed with either control or N-terminal antibodies. 
These experiments show that CCHL with an attached C-terminal antibody may form 
a membrane-spanning translocation intermediate in the O M . From the size of the 
observed fragments of 34, 28, and 22 kDa, it can be concluded that the N-terminal 
half of the protein (i) enters the O M first, and (ii) contains the information for both 
interaction with and translocation through the O M . Preliminary experiments with 
truncated CCHL proteins corroborate this result. The putative import signal must be 
contained within 150 central amino acids, since 80 N-terminal and 130 C-terminal 
amino acids can be deleted from C C H L without any influence on the import 
efficiency (G. Kispal, R. L i l l and W. Neupert, unpublished results). Further experi-
ments are necessary to define the precise location and the chemical character of the 
import signal in CCHL. 
Aside from describing a novel import pathway into the IMS, our studies on CCHL 
import bear relevance to the general protein import pathway into mitochondria. 
Import of proteins across the O M is not necessarily coupled to translocation across 
the I M , i.e. the two translocation machineries in the two membranes do not 
necessarily form a continuous channel. Indication for this has come already from 
studies on translocation intermediates in the IMS en route to the matrix. Segments of 
the polypeptide chains in transit are accessible to added protease after rupture of the 
O M indicating that the intermediates are exposed to the IMS [40,41]. Sequential 
transfer across the O M and I M in intact mitochondria was observed for CCHL 
fusion proteins carrying a matrix targeting sequence at the N-terminus (Fig. 2B). 
Without a membrane potential, the fusion proteins were imported into the IMS like 
CCHL itself. Upon establishing a membrane potential, at least the N-terminus of the 
proteins was transferred from the IMS to the matrix as indicated by the cleavage of 
the signal sequence (G. Kispal, R. Li l l and W. Neupert, unpublished results). Taken 
together, these data suggest that transport across the O M and I M can occur 
sequentially by using two principally independent translocation machineries 
[17,42]. Contact sites between the O M and I M may then be considered as dynamic 
structures that kinetically accelerate import across both membranes and thus may 
represent the structure that is predominantly used in vivo for the import of proteins 
into the matrix. 
5. Perspectives 
Future work on mitochondrial protein import has to concentrate on questions in 
two major directions. First, the as yet unknown components of the mitochondrial 
protein sorting apparatus have to be identified. Most importantly, these are the 
constituents of the import and export machineries in the I M . Furthermore, transit 
through and folding within the IMS may be mediated by still unidentified factors. 
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Drawing the analogy to the bacterial system, the participation of other chaperones 
in protein folding and assembly into oligomeric structures may be anticipated, e.g., 
activities like that of GroES or DnaJ homologs (see Chapters 25 and 26). Finally, 
other catalysts of post-translational modifications like new proteolytic processing 
activities may be discovered. 
The second question is how the known components function and cooperate to 
finally achieve the correct localization and assembly of incoming proteins. This is a 
major challenge, but the discovery that translocation through the two membranes 
may be considered as two independent steps, will eventually allow to individually 
study the transit through the two membranes. It is thus easy to predict that future 
research on mitochondrial protein targeting and sorting will be as exciting as it has 
been in the past. 
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